Daniel Gardette
Blaise Pascal University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daniel Gardette.
Nuclear Medicine and Biology | 2001
Nicole Moins; Janine Papon; Hélène Seguin; Daniel Gardette; Marie-France Moreau; Pierre Labarre; Martine Bayle; J. Michelot; Jean-Claude Gramain; Jean-Claude Madelmont; Annie Veyre
Iodobenzamides are reported to possess some affinity for melanoma. In order to identify the compound having the most appropriate pharmacokinetic properties as a potential melanoma imaging agent, thirteen new [125I]radioiodobenzamides with a butylene amide-amine spacer and various substituents on the terminal amino group were investigated. Their synthesis, radioiodination and biodistribution in B16 melanoma bearing C57BL6 mice are described and compared to [125I] labeled N-(2-diethylaminoethyl)-4-iodobenzamide ([125I]BZA), our reference compound. Changes in the terminal amino constituents induced modifications of lipophilicity, tumor uptake and organ distribution. The dimethylaminobutyl iodobenzamide appeared to be the most promising radiopharmaceutical imaging agent for the detection of melanoma and its metastases.
Bioorganic & Medicinal Chemistry | 2002
Valérie Weber; Pascal Coudert; Catherine Rubat; Eliane Duroux; Danielle Vallee-Goyet; Daniel Gardette; Marc Bria; Eliane Albuisson; Fernand Leal; Jean-Claude Gramain; Jacques Couquelet; Michel Madesclaire
In order to study the effect of phenol moieties on biological activities of ascorbic acid derivatives, we synthesized 13 novel 4,5-diaryl-3-hydroxy-2(5H)-furanones 5a-m with various substitution patterns. Compound 5 g bearing a 2,3-dihydroxy phenyl ring on the 5-position of the heterocycle appeared to be the most powerful anti-oxidant furanone with reducing activity against DPPH (IC(50)=10.3 microM), superoxide anion quenching capacity (IC(50)=0.187 mM) and lipid peroxidation inhibitory effect (IC(50)=0.129 mM). To ascertain determinant molecular features for anti-oxidant activities, structure-activity relationships were studied. Lipophilicity and molecular parameters related to electron distribution and structure (difference in heats of formation between the compound and its radical or its cation radical, energy of the highest occupied molecular orbital, HOMO) were found to correlate with the anti-oxidant action of compounds 5 in the different tests used. Oxygen-derived free radicals are known to contribute to inflammatory disorders; therefore we have investigated effects of compounds 5 in two models of inflammation: phorbol ester-induced ear edema in mice (TPA-test) and carrageenan-induced paw edema in rat. At 100 mg/kg ip in the TPA-test, the anti-inflammatory activity of compounds 5 was potent compared with that of indomethacin and ketorolac and all the results suggested a cyclooxygenase inhibition in the emergence of such properties. The combined pharmacological actions of compounds 5 associated with a favorable therapeutic index prompt with interesting perspectives for their use in heart and brain disorders as well as in inflammatory diseases.
Bioorganic & Medicinal Chemistry | 1998
Stéphane Moreau; Pascal Coudert; Catherine Rubat; Danielle Vallee-Goyet; Daniel Gardette; Jean-Claude Gramain; Jacques Couquelet
Analogues of 3-amino-7-(2,6-dichlorobenzyl)-6-methyltriazolo[4,3-b]pyridazine PC25 containing amide or carboxylic acid function were synthesized and tested for anticonvulsant activity. The compounds having the imidazole ring substituted with an amide group have been found to be generally more active against maximal electroshock-induced seizures in mice (15.2 < or = ED50 < or = 37.5 mg kg(-1) orally). Furthermore, maximum activity was generally associated with a 2,6-dichlorobenzyl substitution pattern. 3-Amido-7-(2,6-dichlorobenzyl)-6-methyltriazolo[4,3-b]pyridazine 4b was also protective in the pentylenetetrazole-induced seizures test (ED50 = 91.1 mg kg(-1) orally) and blocked strychnine-induced tonic extensor seizures (ED50 = 62.9 mg kg(-1) orally). Moreover, calculated electrostatic isopotential maps of the whole active compounds were quite similar and, consequently, could be associated to optimum anticonvulsant activity.
Tetrahedron-asymmetry | 1998
Daniel Gardette; Yvonne Gelas-Mialhe; Jean-Claude Gramain; Bertrand Perrin; Roland Remuson
Abstract The enantioselective synthesis of (+)-myrtine 1 and (−)-epimyrtine 2 is described starting from ( S )-2-(2-hydroxypropyl)allyltrimethylsilane 4 using an intramolecular allylsilane N -acyliminium ion cyclization.
Tetrahedron Letters | 2000
Fanny Bois; Daniel Gardette; Jean-Claude Gramain
(S)-(+)-Pipecoline and both enantiomers of coniine were synthesized, in good yields, by a reductive photocyclization of chiral dienamides. Enantioselectivities of up to 75% were obtained.
Tetrahedron Letters | 1992
G. Haviari; Jean-Pierre Célérier; H. Petit; G. Lhommet; Daniel Gardette; Jean-Claude Gramain
Abstract Cyclic β-enamino esters prepared from chiral α-methylbenzylamines are catalytically reduced with high a diastereoisomeric excess.
Synthetic Communications | 1998
Hélène Seguin; Daniel Gardette; Marie-France Moreau; Jean-Claude Madelmont; Jean-Claude Gramain
Abstract A general method for the synthesis of N,N-dialkylaminobutylamines 4 from readily available chloroacetamides 6 is described.
Synthetic Communications | 1997
Malika Ibrahim-Ouali; Marie-Eve Sinibaldi; Yves Troin; Daniel Gardette; Jean-Claude Gramain
Abstract The synthesis of original allenic lactams 2 and allenic esters 5 is presented and their Michael condensation with N-benzylaniline described.
Journal of Medicinal Chemistry | 1994
Stephane Moreau; Pascal Coudert; Catherine Rubat; Daniel Gardette; Danielle Vallee-Goyet; Jacques Couquelet; Pierre Bastide; P. Tronche
Journal of Medicinal Chemistry | 1997
Emmanuelle Mounetou; Eric Debiton; Catherine Buchdahl; Daniel Gardette; Jean-Claude Gramain; Jean-Claude Maurizis; and Annie Veyre; Jean-Claude Madelmont